相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis
Lifu Sheng et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
Un Jung Kang et al.
MOVEMENT DISORDERS (2019)
New windows into the brain: Central nervous system-derived extracellular vesicles in blood
Min Shi et al.
PROGRESS IN NEUROBIOLOGY (2019)
Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease
Chen Tian et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment
Debjani Guha et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease
Min Shi et al.
ALZHEIMERS & DEMENTIA (2018)
ELISA method to detect α-synuclein oligomers in cell and animal models
Louise Berkhoudt Lassen et al.
PLOS ONE (2018)
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies
Anne Stuendl et al.
BRAIN (2016)
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang et al.
ACTA NEUROPATHOLOGICA (2016)
CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease
Min Shi et al.
ALZHEIMERS & DEMENTIA (2016)
Extracellular vesicle isolation and characterization: toward clinical application
Rong Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
Nour K. Majbour et al.
MOLECULAR NEURODEGENERATION (2016)
Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers
Alexander G. Thompson et al.
NATURE REVIEWS NEUROLOGY (2016)
Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease
Yue Yang et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity
Tessandra Stewart et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease
Min Shi et al.
ACTA NEUROPATHOLOGICA (2014)
Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing
E. van der Pol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Recent developments in biomarkers in Parkinson disease
Anthony H. V. Schapira
CURRENT OPINION IN NEUROLOGY (2013)
PARKINSON DISEASE New guidelines for diagnosis of Parkinson disease
Maria Jose Marti et al.
NATURE REVIEWS NEUROLOGY (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Parkinson's Disease: Genetics and Pathogenesis
Joshua M. Shulman et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
Ignacio F. Mata et al.
ARCHIVES OF NEUROLOGY (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Optical and non-optical methods for detection and characterization of microparticles and exosomes
E. van der Pol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
The L1 cell adhesion molecule is a potential biomarker of human distal nephron injury in acute tubular necrosis
Y. Allory et al.
KIDNEY INTERNATIONAL (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
AJ Hughes et al.
NEUROLOGY (2001)
分享论文
